Literature DB >> 12106741

Opacification of a hydrophilic acrylic intraocular lens with exacerbation of Behçet's uveitis.

Chan Y Kim1, Shin J Kang, Sung J Lee, Sung H Park, Hyoung J Koh.   

Abstract

Behçet's disease is 1 of the most common causes of uveitis in the Eastern world. Its common ocular complications are uveitis, cataract, and obliteration of retinal vessels. Phacoemulsification with intraocular lens (IOL) implantation in patients with Behçet's disease is known to be a safe procedure. We managed a patient with Behçet's disease who had aggravated uveitis and opacification of a hydrophilic acrylic IOL (ACRL-C160, Ophthalmed) 4 months after cataract surgery. Recalcitrant uveitis despite maximum tolerable medication and IOL opacification with vitreous opacity necessitated an IOL exchange and trans pars plana vitrectomy. After the procedure, the eye became quiescent. However, the visual acuity was 20/200 because of the obliteration of retinal vessels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106741     DOI: 10.1016/s0886-3350(02)01356-1

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

1.  Spontaneous resolution of early postoperative intraocular lens opacification in a patient with uveitis.

Authors:  J Wong; A Jap; S-P Chee
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

2.  Ultrastructural evaluation of explanted opacified Hydroview (H60M) intraocular lenses.

Authors:  Nathaniel E Knox Cartwright; Eric J Mayer; Brendan M McDonald; Andrew Skinner; Chris J Salter; Derek M Tole; John M Sparrow; Andrew D Dick; David J P Ferguson
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

3.  Reversible opacification of hydrophobic acrylic intraocular lens- two cases report.

Authors:  Dong Ju Kim; Roy S Chuck; Jimmy K Lee; Choul Yong Park
Journal:  BMC Ophthalmol       Date:  2017-06-30       Impact factor: 2.209

4.  Combined phacovitrectomy with preoperative cyclosporin A in management of resistant panuveitis.

Authors:  Mohammad A Rashad
Journal:  Clin Ophthalmol       Date:  2012-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.